These findings suggest that CDK1, STAT1, COL1A2, and COL1A1 may be involved in the AKI process associated with gastrointestinal cancers through mechanisms such as cell cycle regulation and inflammation, highlighting their potential as early predictive and diagnostic biomarkers for AKI. This evidence concerns the gene CDK1 and acute kidney injury.